Cargando…
Improving routine outpatient monitoring for patients with sickle-cell disease on hydroxyurea
Hydroxyurea is the gold standard treatment for prevention of vaso-occlusive crises in patients with sickle-cell anaemia. It has a narrow therapeutic index and dangerous side effects including cytopenias. There is high variation in dose–response across the population. Therefore, a robust outpatient m...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5878251/ https://www.ncbi.nlm.nih.gov/pubmed/29610772 http://dx.doi.org/10.1136/bmjoq-2017-000218 |